AMLX (amylyx.com) Company Projected Revenue

Amylyx Pharmaceuticals Inc - graphic logo of issuer AMLX

High risks and fierce competition with market behemoths are weighing on the credit profile of Amylyx Pharmaceuticals (AMLX). The projected sales trajectory for products contained within the GURU.Markets platform demonstrates volatility, where 0.00 serves as the final level mark. Financial stability currently relies on the search for new molecules to treat Wolfram syndrome, which is intended to mitigate the fallout from the reputational collapse following the recall of the primary drug.

AMLX - Amylyx Corp Company Future Revenue over the range 07/04/2022 - 11/17/2026

Financial and market metric breakdowns for Amylyx Corp (AMLX)

- business market valuation indicators:
Fundamental company analysis:amylyx.com
Signature product of Amylyx

Effective diversification of distribution channels for Amylyx Pharmaceuticals (AMLX) neurological drugs guarantees a stable revenue stream and high margins even during market disruptions. An analysis of the firm's sales volume benchmarks allows for an assessment of the business's fundamental resilience amid turbulence, where daily monitoring of risk mandate deviations helps investors classify the asset by reliability level and avoid impulsive decisions.

Analysis of competing companies

Company Future Sales Volume BIIB (Biogen)|NBIX (Neurocrine Biosciences, Inc.) - Company Future Revenue|Company Projected Revenue Regencell RGC|Company Projected Revenue Volume AXSM (Axsome Therapeutics Inc)|ACADIA Pharmaceuticals - Projected Sales Volume|XENE - Projected Sales Volume|VKTX: Projected Sales Volume|Company Expected Revenue SUPN (Supernus)|CPRX (Catalyst Pharmaceuticals Inc) - Projected Sales Volume|DNLI: Company Future Revenue|Company Projected Revenue harmonybiosciences.com (HRMY)|Biohaven - Company Revenue Forecast|Projected Sales Volume TRVI (Trevi Corp)|Company Future Sales Praxis Precision Medicines, Inc. (PRAX)|Anavex Life Sciences Corp - Projected Sales Volume|CeriBell Corp (CBLL) - Company Future Sales Volume|Prothena Corp (PRTA) - Company Projected Revenue|Company Expected Sales Volume Alector Inc. (ALEC)|Company Future Sales Volume ANNX|omeros.com (OMER) - Company Future Sales|Company Projected Revenue Neurogene Inc. (NGNE)|ACIU (AC Immune Inc) - Company Future Revenue|Projected Sales Volume VYGR (voyagertherapeutics.com)|Company Future Sales Neumora Therapeutics (NMRA)|SCLX - Company Projected Revenue|Company Sales Forecast Tevogen Bio Holdings Inc. (TVGN)|Alpha Cognition (ACOG) - Company Projected Revenue|CGTX - Company Future Sales|IKT (inhibikase.com) - Projected Sales Volume|cassavasciences.com (SAVA) - Company Future Sales|Company Future Sales Volume ASRT (Assertio Therapeutics)|Company Future Sales Coya Therapeutics|Vistagen - Company Future Sales Volume|ovidrx.com (OVID) - Company Expected Sales Volume|Acumen Pharmaceuticals - Projected Sales Volume|Company Expected Sales Volume cervomed.com|ATHE: Projected Sales Volume|Clene Inc - Company Future Revenue|Company Projected Revenue PepGen|JUNS (Jupiter Neurosciences Inc) - Company Projected Revenue Volume|Company Future Sales Volume RLMD (Relmada Corp)|annovisbio.com - Company Revenue Forecast|Company Projected Revenue gracetx.com GRCE|AIFF (Firefly Neuroscience, Inc.) - Company Expected Revenue|KLTO - Company Projected Revenue|Company Expected Sales Volume NeuroSense Therapeutics Ltd|Reviva Pharmaceuticals (RVPH) - Company Projected Revenue|Company Revenue Forecast MTVA|Company Future Sales Volume NRXS|Company Future Sales Volume Helius Medical (HSDT)|Projected Sales Volume PASG|Neuphoria Therapeutics - Company Revenue Forecast|Company Projected Revenue Minerva Neurosciences, Inc. NERV|Projected Sales Volume Athira Pharma ATHA|ADXN: Company Future Sales Volume|Company Expected Sales Volume Alzamend Neuro|Cyclerion Therapeutics Inc. (CYCN) - Company Projected Revenue|Company Expected Sales Volume Protagenic Therapeutics (PTIX)|KTTA (pasitheaclinics.com) - Projected Sales Volume|Company Future Sales Volume Cortigent (CRGT)|Projected Sales Volume ATXI|BCLI - Company Expected Sales Volume|Projected Sales Volume CARA (Cara Therapeutics, Inc)|Chromocell Therapeutics Corporation (CHRO) - Company Expected Sales Volume|ELYM - Company Projected Revenue|Company Sales Forecast intracellulartherapies.com (ITCI)|Longboard (LBPH) - Company Projected Revenue|Marinus Pharmaceuticals Inc - Company Future Revenue|Company Future Sales Volume NKGN|NeuroBo - Company Expected Revenue|Company Projected Revenue Sage Therapeutics, Inc (SAGE)|Company Future Sales Volume Synaptogenix SNPX|Trevena, Inc. - Company Future Sales Volume|VIGL: Company Revenue Forecast|WENA: Company Future Sales Volume|Company Expected Sales Volume Cerevel Therapeutics